Association of monosodium glutamate intake with overweight in Chinese adults: The INTERMAP study

Obesity

Volumn 16, Issue 8, 2008, Pages 1875-1880

  He, Ka ^a,b   Zhao, Liancheng ^c   Daviglus, Martha L ^d   Dyer, Alan R ^d   Van Horn, Linda ^d   Garside, Daniel ^d   Zhu, Liguang ^e   Guo, Dongshuang ^f   Wu, Yangfeng ^c   Zhou, Beifan ^c   Stamler, Jeremiah ^d  

^a University of North Carolina   (United States)

^b IL   (United States)

^c FUWAI HOSPITAL   (China)

^d NORTHWESTERN UNIVERSITY   (United States)

^e GUANGXI MEDICAL UNIVERSITY   (China)

^f Yu County Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE SODIUM;

ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHINA; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PHYSIOLOGY; PREVALENCE; WORLD HEALTH ORGANIZATION;

BODY MASS INDEX; BODY WEIGHT; CHINA; CROSS-SECTIONAL STUDIES; ENERGY INTAKE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; OVERWEIGHT; PREVALENCE; SODIUM GLUTAMATE; WORLD HEALTH ORGANIZATION;

ANIMALIA;

EID: 48749124598     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.274     Document Type: Article

References (40)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
2. Zemel MB. Role of calcium and dairy products in energy partitioning and weight management. Am J Clin Nutr 2004;79:907S-912S.
3. Raben A, Agerholm-Larsen L, Flint A, Holst JJ, Astrup A. Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake. Am J Clin Nutr 2003;77:91-100.
4. U.S. Food and Drug Administration, FDA and Monosodium Glutamate (MSG). 〈http://www.cfsan.fda.gov/~lrd/msg.html〉. Accessed 22 January 2008.
5. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-721.
6. Dawson R, Pelleymounter MA, Millard WJ, Liu S, Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol 1997;273: E202-E206.
7. Tang-Christensen M, Holst JJ, Hartmann B, Vrang N. The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin. Neuroreport 1999;10:1183-1187.
8. Bergen HT, Mizuno TM, Taylor J, Mobbs CV. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin. Endocrinology 1998;139:4483-4488.
9. Hermanussen M, Tresguerres JA. Does high glutamate intake cause obesity? J Pediatr Endocrinol Metab 2003;16:965-968.
10. Hermanussen M, Tresguerres JA. Does the thrifty phenotype result from chronic glutamate intoxication? A hypothesis. J Perinat Med 2003;31:489-495.
11. Kawakita T. L-monosodium glutamate (MSG). In: Kirk-Othmer Encyclopedia of Chemical Technology, 4th edn, Vol 2. Inter-Science-Wiley, 1992, p. 571.
12. Hermanussen M, García AP, Sunder M et al. Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite. Eur J Clin Nutr 2006;60:25-31.
13. Stamler J, Elliott P, Dennis B et al. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens 2003;17:591-608.
14. Dennis B, Stamler J, Buzzard M et al. INTERMAP: the dietary data - process and quality control. J Hum Hypertens 2003;17:609-622.
15. Zhou BF, Stamler J, Dennis B et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens 2003;17:623-630.
16. Schakel SF, Dennis BH, Wold AC et al. Enhancing data on nutrient composition of foods eaten by participants in the INTERMAP Study in China, Japan, the United Kingdom and the United States. J Food Compos Anal 2003;16:395-408.
17. Elliott P, Stamler R. Manual of operations for "INTERSALT", an international cooperative study on the relation of sodium and potassium to blood pressure. Control Clin Trials 1988;9(Suppl 2):1S-117S.
18. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
19. International Obesity Task Force (on behalf of the Steering Committee). The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Western Pacific Region. Health Communications Australia, Sydney, 2002.
20. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science 1969;166:386-388.
21. Arees EA, Mayer J. Monosodium glutamate-induced brain lesions: electron microscopic examination. Science 1970;170:549-550.
22. Pizzi WJ, Barnhart JE, Fanslow DJ. Monosodium glutamate administration to the newborn reduces reproductive ability in female and male mice. Science 1977;196:452-454.
23. Simson EL, Gold RM, Standish LJ, Pellett PL. Axon-sparing brain lesioning technique: the use of monosodium-L-glutamate and other amino acids. Science 1977;198:515-517.
24. Olney JW, Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 1970;227:609-611.
25. Olney JW. Brain damage and oral intake of certain amino acids. In: Levi G, Battistin L, Lajtha A (eds). Transport Phenomena in the Nervous System: Physiological and Pathological Aspects. Plenum: New York, 1976.
26. Olney JW. Excitotoxic food additives - relevance of animal studies to human safety. Neurobehav Toxicol Teratol 1984;6:455-462.
27. Olney JW. Food additives, excitotoxic. In: Adelman G (ed). Encyclopedia of Neuroscience. Birkhauser: Boston, 1987, pp 436-438.
28. Monno A et al. Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate. Neurosci Lett 1995;193:45-48.
29. Beyreuther K, Biesalski HK, Fernstrom JD et al. Consensus meeting: monosodium glutamate - an update. Eur J Clin Nutr 2007;61:304-313.
30. Campfield, LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
31. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
32. Mercer JG, Hoggard N, Williams LM et al. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996;8:733-735.
33. Frederich RC, Löllmann B, Hamann A et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995;96:1658-1663.
34. Bray GA. Syndromes of hypothalamic obesity in man. Pediatr Ann 1984;13:525-536.
35. Pinkney J, Wilding J, Williams G, MacFarlane I. Hypothalamic obesity in humans: what do we know and what can be done? Obes Rev 2002;3:27-34.
36. Meister B, Ceccatelli S, Hökfelt T et al. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp Brain Res 1989;76:343-368.
37. Flier JS, Cook KS, Usher P, Spiegelman BM. Severely impaired adipsin expression in genetic and acquired obesity. Science 1987;237:405-408.
38. Spurlock ME, Hahn KJ, Miner JL. Regulation of adipsin and body composition in the monosodium glutamate (MSG)-treated mouse. Physiol Behav 1996;60:1217-1221.
39. Choi S, Sparks R, Clay M, Dallman MF. Rats with hypothalamic obesity are insensitive to central leptin injections. Endocrinology 1999;140:4426-4433.
40. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normalweight and obese humans. N Engl J Med 1996;334:292-295.